Does ONARTUZUMAB Cause Malignant neoplasm progression? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Malignant neoplasm progression have been filed in association with ONARTUZUMAB. This represents 8.2% of all adverse event reports for ONARTUZUMAB.
8
Reports of Malignant neoplasm progression with ONARTUZUMAB
8.2%
of all ONARTUZUMAB reports
4
Deaths
8
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ONARTUZUMAB?
Of the 8 reports, 4 (50.0%) resulted in death, 8 (100.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ONARTUZUMAB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does ONARTUZUMAB Cause?
Pyrexia (12)
Dehydration (11)
Vomiting (11)
Fatigue (9)
Nausea (9)
Decreased appetite (8)
Diarrhoea (8)
Oedema peripheral (8)
Pneumonia (8)
Pulmonary embolism (8)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)